Benzodiazepine Drugs Market By Product, Application and Distribution Channel - Global Industry Analysis & Forecast to 2025

Published On : February 2019 Pages : 165 Category: Pharma & Healthcare Report Code : HC022457

Benzodiazepine Drugs Market By Product (Clonazepam, Lorazepam, Alprazolam, Diazepam) Application (Insomnia, Seizures, Anxiety, Alcohol Withdrawal) Distribution Channel (Retail Pharmacies, Hospitals Pharmacies) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Benzodiazepine Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.  Benzodiazepine is a class of psychoactive medications that are utilized to treat insomnia, anxiety, panic disorder, alcohol withdrawal, and seizures. These medications produce a quieting impact by upgrading the impact of the neurotransmitter GABA. Benzodiazepines are broadly endorsed medications over the world. They are useful to lessen seizures, anxiety, inducing sleep, relax muscles, and utilized for sedation purposes preceding medical procedure or general anesthesia.

Drivers and Restraints

The market for benzodiazepine drugs is extending essentially because of the ascent in predominance of seizures, anxiety, insomnia, and increment in worry among individuals about preventive estimates with respect to pressure related conditions. Rising adoption of conventional medications and relatively higher medicines for benzodiazepines, when contrasted with other psychoactive medications, likewise drive the market.

Regional Insights

North America overwhelmed the worldwide benzodiazepine drugs market in 2017, inferable from the ascent in commonness of tension and related conditions and higher FDA approvals of benzodiazepine medicates by real players in the locale.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • F.Hoffmann-La Roche Ltd
  • Mylan, N.V
  • H.Lundbeck A/S
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma
  • Pfizer Inc
  • Bausch Health Companies, Inc
  • Teva Pharmaceutical Industries Ltd
  • Apotex Inc

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Benzodiazepine Drugs Market, By Product, Estimates and Forecast, 2014-2025($Billion)

o    Clonazepam

o    Lorazepam

o    Alprazolam

o    Diazepam

·         Benzodiazepine Drugs Market, By Application, Estimates and Forecast, 2014-2025($Billion)

o    Insomnia

o    Seizures

o    Anxiety

o    Alcohol Withdrawal

·         Benzodiazepine Drugs Market, By Distribution Channel, Estimates and Forecast, 2014-2025($Billion)

o    Retail Pharmacies

o    Hospitals Pharmacies

·         Benzodiazepine Drugs Market, By Region, Estimates and Forecast, 2014-2025($Billion)

o    North America

§  North America Benzodiazepine Drugs Market, By Country

o    U.S. Benzodiazepine Drugs Market

o    Canada Benzodiazepine Drugs Market

o    Mexico Benzodiazepine Drugs Market

o    Europe

§  Europe Benzodiazepine Drugs Market, By Country

o    Germany Benzodiazepine Drugs Market

o    UK Benzodiazepine Drugs Market

o    France Benzodiazepine Drugs Market

o    Russia Benzodiazepine Drugs Market

o    Italy Benzodiazepine Drugs Market

o    Rest of Europe Benzodiazepine Drugs Market

o    Asia-Pacific

§  Asia-Pacific Benzodiazepine Drugs Market, By Country

o    China Benzodiazepine Drugs Market

o    Japan Benzodiazepine Drugs Market

o    South Korea Benzodiazepine Drugs Market

o    India Benzodiazepine Drugs Market

o    Southeast Asia Benzodiazepine Drugs Market

o    Rest of Asia-Pacific Benzodiazepine Drugs Market

o    South America

§  South America Benzodiazepine Drugs Market

o    Brazil Benzodiazepine Drugs Market

o    Argentina Benzodiazepine Drugs Market

o    Columbia Benzodiazepine Drugs Market

o    Rest of South America Benzodiazepine Drugs Market

o    Middle East and Africa

§  Middle East and Africa Benzodiazepine Drugs Market

o    Saudi Arabia Benzodiazepine Drugs Market

o    UAE Benzodiazepine Drugs Market

o    Egypt Benzodiazepine Drugs Market

o    Nigeria Benzodiazepine Drugs Market

o    South Africa Benzodiazepine Drugs Market

o    Rest of MEA Benzodiazepine Drugs Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Benzodiazepine Drugs Market, By Product

5.1.     Introduction

5.2.     Global Benzodiazepine Drugs Revenue and Market Share by Product  (2014-2018)

5.2.1.  Global Benzodiazepine Drugs Revenue and Revenue Share by Product  (2014-2018)

5.3.     Clonazepam

5.3.1.  Global Clonazepam Revenue and Growth Rate (2014-2018)

5.4.     Lorazepam

5.4.1.  Global Lorazepam Revenue and Growth Rate (2014-2018)

5.5.     Alprazolam

5.5.1.  Global Alprazolam Revenue and Growth Rate (2014-2018)

5.6.     Diazepam

5.6.1.  Global Diazepam Revenue and Growth Rate (2014-2018)

6.       Benzodiazepine Drugs Market, By Application

6.1.     Introduction

6.2.     Global Benzodiazepine Drugs Revenue and Market Share by Application  (2014-2018)

6.2.1.  Global Benzodiazepine Drugs Revenue and Revenue Share by Application  (2014-2018)

6.3.     Insomnia

6.3.1.  Global Insomnia Revenue and Growth Rate (2014-2018)

6.4.     Seizures

6.4.1.  Global Seizures Revenue and Growth Rate (2014-2018)

6.5.     Anxiety

6.5.1.  Global Anxiety Revenue and Growth Rate (2014-2018)

6.6.     Alcohol Withdrawal

6.6.1.  Global Alcohol Withdrawal Revenue and Growth Rate (2014-2018)

7.       Benzodiazepine Drugs Market, By Distribution Channel

7.1.     Introduction

7.2.     Global Benzodiazepine Drugs Revenue and Market Share by Distribution Channel (2014-2018)

7.2.1.  Global Benzodiazepine Drugs Revenue and Revenue Share by Distribution Channel (2014-2018)

7.3.     Retail Pharmacies

7.3.1.  Global Retail Pharmacies Revenue and Growth Rate (2014-2018)

7.4.     Hospitals Pharmacies

7.4.1.  Global Hospitals Pharmacies Revenue and Growth Rate (2014-2018)

8.       Benzodiazepine Drugs Market, By Region

8.1.     Introduction

8.2.     Global Benzodiazepine Drugs Revenue and Market Share by Regions

8.2.1.  Global Benzodiazepine Drugs Revenue by Regions (2014-2018)

8.3.     North America Benzodiazepine Drugs by Countries

8.3.1.  North America Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)

8.3.2.  North America Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Benzodiazepine Drugs by Countries

8.4.1.  Europe Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Benzodiazepine Drugs by Countries

8.5.1.  Asia-Pacific Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Benzodiazepine Drugs by Countries

8.6.1.  South America Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)

8.6.2.  South America Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Benzodiazepine Drugs by Countries

8.7.1.  Middle East and Africa Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     F.Hoffmann-La Roche Ltd

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.  Financial Overview

9.2.     Mylan, N.V

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.  Financial Overview

9.3.     H.Lundbeck A.S

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.  Financial Overview

9.4.     Sun Pharmaceutical Industries Ltd

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.  Financial Overview

9.5.     Aurobindo Pharma

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.  Financial Overview

9.6.     Pfizer Inc

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.  Financial Overview

9.7.     Bausch Health Companies, Inc

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.  Financial Overview

9.8.     Teva Pharmaceutical Industries Ltd

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.  Financial Overview

9.9.     Amneal Pharmaceuticals LLC

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.  Financial Overview

9.10. Apotex Inc

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.      Financial Overview

10.    Global Benzodiazepine Drugs Market Competition, by Manufacturer

10.1. Global Benzodiazepine Drugs Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Benzodiazepine Drugs Price By Region (2016-2017)

10.3. Top 5 Benzodiazepine Drugs Manufacturer Market Share

10.4. Market Competition Trend

11.    Benzodiazepine Drugs Market Forecast (2018-2025)

11.1. Global Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Benzodiazepine Drugs Market Forecast by Regions (2018-2025)

11.2.1.      North America Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.1.1. United States Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.1.2. Canada Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.1.3. Mexico Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.      Europe Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.1. Germany Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.2. France Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.3. UK Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.4. Russia Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.5. Italy Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.      Asia-Pacific Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.1. China Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.2. Japan Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.3. Korea Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.4. India Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.4.      South America Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.4.1. Brazil Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.4.2. Argentina Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.4.3. Columbia Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.4.4. Rest of South America Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.      Middle East and Africa Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.3. Egypt Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.4. Nigeria Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.5. South Africa Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.6. Turkey Benzodiazepine Drugs Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Benzodiazepine Drugs Market Forecast (2018-2025)

11.3. Benzodiazepine Drugs Market Forecast by Product  (2018-2025)

11.3.1.      Benzodiazepine Drugs Forecast by Product  (2018-2025)

11.3.2.      Benzodiazepine Drugs Market Share Forecast by Product  (2018-2025)

11.4. Benzodiazepine Drugs Market Forecast by Application  (2018-2025)

11.4.1.      Benzodiazepine Drugs Forecast by Application  (2018-2025)

11.4.2.      Benzodiazepine Drugs Market Share Forecast by Application  (2018-2025)

11.5. Benzodiazepine Drugs Market Forecast by Distribution Channel (2018-2025)

11.5.1.      Benzodiazepine Drugs Forecast by Distribution Channel (2018-2025)

11.5.2.      Benzodiazepine Drugs Market Share Forecast by Distribution Channel (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Benzodiazepine Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Benzodiazepine Drugs Revenue and Revenue Share by Product (2014-2018)
Figure Global Clonazepam Revenue and Growth Rate (2014-2018)
Figure Global Lorazepam Revenue and Growth Rate (2014-2018)
Figure Global Alprazolam Revenue and Growth Rate (2014-2018)
Figure Global Diazepam Revenue and Growth Rate (2014-2018)
Table Global Benzodiazepine Drugs Revenue and Revenue Share by Application (2014-2018)
Figure Global Insomnia Revenue and Growth Rate (2014-2018)
Figure Global Seizures Revenue and Growth Rate (2014-2018)
Figure Global Anxiety Revenue and Growth Rate (2014-2018)
Figure Global Alcohol Withdrawal Revenue and Growth Rate (2014-2018)
Table Global Benzodiazepine Drugs Revenue and Revenue Share by Distribution Channel (2014-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2014-2018)
Figure Global Hospitals Pharmacies Revenue and Growth Rate (2014-2018)
Table Global Benzodiazepine Drugs Revenue by Regions (2014-2018)
Figure North America Benzodiazepine Drugs Growth Rate (2014-2018)
Figure North America Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)
Figure North America Benzodiazepine Drugs by Countries (2014-2018)
Figure North America Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)
Figure United States Benzodiazepine Drugs Growth Rate (2014-2018)
Figure United States Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Canada Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Mexico Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Europe Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)
Figure Europe Benzodiazepine Drugs by Countries (2014-2018)
Figure Europe Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Germany Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Germany Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Benzodiazepine Drugs Growth Rate (2014-2018)
Figure France Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Benzodiazepine Drugs Growth Rate (2014-2018)
Figure UK Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Russia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Italy Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Rest of Europe Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Asia-Pacific Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Benzodiazepine Drugs by Countries (2014-2018)
Figure Asia-Pacific Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)
Figure China Benzodiazepine Drugs Growth Rate (2014-2018)
Figure China Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Japan Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Korea Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Benzodiazepine Drugs Growth Rate (2014-2018)
Figure India Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Southeast Asia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Benzodiazepine Drugs Growth Rate (2014-2018)
Figure South America Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)
Figure South America Benzodiazepine Drugs by Countries (2014-2018)
Figure South America Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Brazil Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Argentina Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Columbia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Rest of South America Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Middle East and Africa Benzodiazepine Drugs Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Benzodiazepine Drugs by Countries (2014-2018)
Figure Middle East and Africa Benzodiazepine Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Saudi Arabia Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Benzodiazepine Drugs Growth Rate (2014-2018)
Figure United Arab Emirates Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Egypt Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Nigeria Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Benzodiazepine Drugs Growth Rate (2014-2018)
Figure South Africa Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Turkey Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Benzodiazepine Drugs Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Table F.Hoffmann-La Roche Ltd Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan, N.V Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table H.Lundbeck A.S Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Industries Ltd Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aurobindo Pharma Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bausch Health Companies, Inc Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amneal Pharmaceuticals LLC Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Apotex Inc Benzodiazepine Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Benzodiazepine Drugs Market Share by Manufacturer
Figure Global Benzodiazepine Drugs Revenue and Market Share by Manufacturer
Table Global Benzodiazepine Drugs Price by Region (2016-2017)
Figure Top 5 Benzodiazepine Drugs Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Benzodiazepine Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Benzodiazepine Drugs Market Forecast by Regions (2018-2025)
Figure North America Benzodiazepine Drugs Market Forecast (2018-2025)
Figure United States Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Canada Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Mexico Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Europe Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Germany Benzodiazepine Drugs Market Forecast (2018-2025)
Figure France Benzodiazepine Drugs Market Forecast (2018-2025)
Figure UK Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Russia Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Italy Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Rest of Europe Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Benzodiazepine Drugs Market Forecast (2018-2025)
Figure China Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Japan Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Korea Benzodiazepine Drugs Market Forecast (2018-2025)
Figure India Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Southeast Asia Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Benzodiazepine Drugs Market Forecast (2018-2025)
Figure South America Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Brazil Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Argentina Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Columbia Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Rest of South America Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Benzodiazepine Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Egypt Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Nigeria Benzodiazepine Drugs Market Forecast (2018-2025)
Figure South Africa Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Turkey Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Benzodiazepine Drugs Market Forecast (2018-2025)
Figure Global Benzodiazepine Drugs Forecast by Product (2018-2025)
Figure Global Benzodiazepine Drugs Market Share Forecast by Product (2018-2025)
Figure Global Benzodiazepine Drugs Forecast by Product (2018-2025)
Figure Global Benzodiazepine Drugs Forecast by Application (2018-2025)
Figure Global Benzodiazepine Drugs Market Share Forecast by Application (2018-2025)
Figure Global Benzodiazepine Drugs Forecast by Application (2018-2025)
Figure Global Benzodiazepine Drugs Forecast by Distribution Channel (2018-2025)
Figure Global Benzodiazepine Drugs Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Benzodiazepine Drugs Forecast by Distribution Channel (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*